{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:57:27Z","timestamp":1790708247846,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.clgc.2026.102665","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T06:44:34Z","timestamp":1788677074000},"page":"102665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual-Tracer 68Ga-PSMA and 68Ga-DOTATATE PET\/CT in Advanced Prostate Cancer: Persistent PSMA Expression Despite Clinically Suspected Treatment-Emergent Neuroendocrine Differentiation"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2518-114X","authenticated-orcid":false,"given":"Hiroki","family":"Sai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Kuruma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuya","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1124-2322","authenticated-orcid":false,"given":"Yuki","family":"Enei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7410-0712","authenticated-orcid":false,"given":"Takafumi","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieko","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusuke","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat","family":"Lenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5673-1553","authenticated-orcid":false,"given":"Takahiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2026.102665_bib0001","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241269676","article-title":"Promising therapy for neuroendocrine prostate cancer: current status and future directions","volume":"16","author":"Fei","year":"2024","journal-title":"Ther Adv Med Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2026.102665_bib0002","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/pros.24664","article-title":"Diagnosis and management of neuroendocrine prostate cancer","volume":"84","author":"de Kouchkovsky","year":"2024","journal-title":"Prostate"},{"issue":"10","key":"10.1016\/j.clgc.2026.102665_bib0003","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00432-024-05983-0","article-title":"Unraveling molecular characteristics and tumor microenvironment dynamics of neuroendocrine prostate cancer","volume":"150","author":"Heimd\u00f6rfer","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"issue":"17","key":"10.1016\/j.clgc.2026.102665_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15174404","article-title":"PET\/CT and conventional imaging for the assessment of neuroendocrine prostate cancer: a systematic review","volume":"15","author":"Dondi","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.clgc.2026.102665_bib0005","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.2967\/jnumed.111.101675","article-title":"The role of 68Ga-DOTATATE PET\/CT in suspected neuroendocrine tumors","volume":"53","author":"Haug","year":"2012","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.clgc.2026.102665_bib0006","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12964-026-02795-2","article-title":"Deciphering double-negative prostate cancer: from aggressive subtype to novel therapeutic paradigms","volume":"24","author":"Wang","year":"2026","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.clgc.2026.102665_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2026.105499","article-title":"Double-negative prostate cancer: evolutionary mechanisms, microenvironmental remodeling, and clinical translation","author":"Fan","year":"2026","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102665_bib0008","article-title":"Multitarget molecular imaging in metastatic castration-resistant adenocarcinoma prostate cancer with therapy-induced neuroendocrine differentiation","volume":"12","author":"Vargas Ahumada","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"24","key":"10.1016\/j.clgc.2026.102665_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246039","article-title":"Prognostic evaluation of metastatic castration-resistant prostate cancer and neuroendocrine prostate cancer with [68Ga]Ga-DOTATATE PET-CT","volume":"14","author":"Bilen","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.clgc.2026.102665_bib0010","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/j.clgc.2021.01.008","article-title":"Molecular imaging of neuroendocrine differentiation of prostate cancer: a case series","volume":"19","author":"Iravani","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2026.102665_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.937713","article-title":"Case report: 18F-PSMA PET\/CT in castration-resistant prostate cancer with aggressive neuroendocrine differentiation","volume":"12","author":"Bergamini","year":"2022","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.clgc.2026.102665_bib0012","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.2967\/jnumed.120.241588","article-title":"Neuroendocrine differentiation and response to PSMA-targeted radioligand therapy in advanced metastatic castration-resistant prostate cancer: a single-center retrospective study","volume":"61","author":"Derlin","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clgc.2026.102665_bib0013","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s43018-023-00539-6","article-title":"Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer","volume":"4","author":"Bakht","year":"2023","journal-title":"Nat Cancer"},{"issue":"14","key":"10.1016\/j.clgc.2026.102665_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143607","article-title":"Target heterogeneity in oncology: the best predictor for differential response to radioligand therapy in neuroendocrine tumors and prostate cancer","volume":"13","author":"Puranik","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clgc.2026.102665_bib0015","doi-asserted-by":"crossref","DOI":"10.1186\/s40644-026-01084-y","article-title":"When PSMA is not enough: the diagnostic blind spots of PSMA PET\/CT and the added value of [\u00b9\u2078F]FDG in high-risk prostate cancer: dual-tracer cohort study","author":"Ibrahim","year":"2026","journal-title":"Cancer Imaging"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:55:54Z","timestamp":1790704554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767326001655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1558767326001655"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102665","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-Tracer 68Ga-PSMA and 68Ga-DOTATATE PET\/CT in Advanced Prostate Cancer: Persistent PSMA Expression Despite Clinically Suspected Treatment-Emergent Neuroendocrine Differentiation","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102665"}}